Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.57 +0.71%

+$0.05 today

Market cap
$144.83M
Beta
1.59
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.19M

Average 0.33M

INGN Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Inogen, Inc.NASDAQ: INGN

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 27.32M shares rose 8.6% year over year, behind the +12.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +5.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +8.6% toward the trailing-twelve-month pace of +12.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
27.32M+0.5% QoQ
Last fiscal yearDec 2025
27.18M+14.9% YoY
LTMMar 2026
26.97M+12.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.6%——
1 year+14.9%——
3-year CAGR+5.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
27.18M USD
Year-over-year change
+14.9%
4-year CAGR
+4.8%

Weighted Avg Shares vs competitors

How INGN compares with its peers on the latest reported figures

  • INGN's LTM Mar 2026 weighted avg shares of 26.97M shares is the 7th highest of the 11 companies compared; the peer median is 44.59M shares.
  • Its year-over-year change of +12.1% is the 7th highest of 11, against a peer median of +14.6%.
  • Over three fiscal years its annual growth of +5.9% compares with a peer median of +10.4%.
INGN Competitors Peer median
Weighted Avg Shares for INGN and competitors
Company Period LTM YoY 3-year CAGR
HCATHealth Catalyst, Inc.LTM Mar 202670.9M +13.1%+9.2%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 202644.51M +24.9%+27.5%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
SIShoulder Innovations, Inc.LTM Mar 202620.52M +3.0%—
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20268.57M +83.3%+80.1%
Peer median (excluding INGN) 44.59M+14.6%+10.4%

Competitors are the stored peer set for INGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue358M377.24M315.66M335.71M348.67M
Cost of Revenue181.52M223.71M188.96M180.96M182.78M
Gross Profit176.48M153.53M126.7M154.74M165.89M
Gross Margin49.3%40.7%40.1%46.1%47.6%
Research & Development16.58M21.94M20.84M21.61M19.4M
Selling, General & Admin150.67M164.67M182.35M175.65M165.07M
Operating Expenses167.24M238.78M236.09M197.26M196.1M
Depreciation & Amortization21.63M23.51M18.15M21M20.66M
EBITDA30.29M(9.57M)(58.34M)(15.47M)(2.72M)
EBITDA Margin8.5%-2.5%-18.5%-4.6%-0.8%
Operating Income9.24M(85.24M)(109.39M)(42.52M)(30.21M)
Operating Margin2.6%-22.6%-34.7%-12.7%-8.7%
Interest Income129K2.84M6.57M5.19M2.15M
Interest Expense00000
Other Income / Expenses(581K)1.98M7.04M6.04M6.83M
Income Before Tax8.66M(83.27M)(102.34M)(36.48M)(23.38M)
Pre-Tax Margin2.4%-22.1%-32.4%-10.9%-6.7%
Income Tax Expense14.99M504K105K(588K)(632K)
Net Income(6.33M)(83.77M)(102.45M)(35.89M)(22.75M)
Net Margin-1.8%-22.2%-32.5%-10.7%-6.5%
EPS (Basic)(0.28)(3.67)(4.42)(1.52)(0.85)
EPS (Diluted)(0.28)(3.67)(4.42)(1.52)(0.85)
Weighted Avg Shares22.49M22.85M23.18M23.65M27.18M
Weighted Avg Shares (Diluted)22.49M22.85M23.18M23.65M27.18M

Inogen, Inc.

NASDAQ:INGN

Intrinsic Alpha fair value

Locked

Current Price

$5.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.